| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Serina Therapeutics, Inc.
13D/A
AGE · 00848H108
|
27.3% |
7/22/2026
Event 3/20/2026
|
||||
| Juvenescence Limited | 27.3% | |||||
| JuvVentures (UK) Limited | 27.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.